Thermoresponsive 3D cell culture scaffolds
A publication in Acta Biomaterialia by a team at Nottingham University, led by Profs Felicity Rose and Cameron Alexander, describes how a thermoresponsive polymer can be incorporated into 3D cell culture scaffolds to facilitate cell release. This thermoresponsive electrospun scaffold system combines the advantages of providing a physiologically relevant environment to maintain a desirable cell… Read more »
Series A VC Finance
The Electrospinning Company has received £1.5 million funding led by London-based venture capital firm Downing Ventures, alongside VC firm MidVen, Newable Private Investing and the Science and Technology Facilities Council. The company, first established in 2010 as a spin-out by the UK Science and Technology Facilities Council, uses technology called electrospinning to design, develop and… Read more »
High-throughput quantification
Nature Communications paper “Deep learning for high-throughput quantification of oligodendrocyte ensheathment at single-cell resolution” by a team at McGill university describes how they established a high-throughput method to assess oligodendrocyte ensheathment in-vitro, combining nanofiber culture devices and automated imaging with a heuristic approach that informed the development of a deep learning analytic algorithm.This is important because… Read more »
Blister pack capability
We have installed a Nelipak blister pack machine in our cleanroom facility. In addition to continual expansion of our electrospinning expertise with different raw materials, we are also increasing our post-processing capabilities. The post-spinning treatment of an electrospun membrane is critical for its use as a medical device or medical device component. Our post-processing capabilities include: Vacuum drying… Read more »
Entrepreneurship recognition IWD2019
Electrospinning’s CEO Ann Kramer was honoured to be invited to a reception for female entrepreneurs at 10 Downing Street to mark International Women’s Day. Ann was selected to meet the prime minister and was delighted to introduce the Company, with a particular focus on the potential for electrospun biomaterials to address problems in gynecological health.
Expanded and Diverse Team
We are pleased to have added new members to our team and are proud of the diversity in the company. Our 50/50 gender balanced team of 14 people has representatives from 9 nationalities and ages from every decade from 20s to 60s. We apply this diversity of approach and background to innovation and problem-solving. In March… Read more »
Successful membrane safety study
A recent publication in British Journal of Ophthalmology by Professor Sheila MacNeil and colleagues at the University of Sheffield and the L.V. Prasad eye clinic in Hyderabad, described how electrospun membranes can be safely applied to rabbit corneas without inducing any local or systemic toxicity. The membranes, made from poly-lactic co-glycolic acid (PLGA) 50:50, were… Read more »
UK Top 10 Healthcare Scale-ups to watch list
The Electrospinning Company has been recognised as one of Britain’s top 10 scale-up companies to watch in healthcare and life sciences, in a list compiled by Capital Cell Investment Manager. More information can be found here.
Appointment of chair
The Electrospinning Company has appointed Dr Stewart White as non-executive chairman. Previously CEO of two life science AIM-quoted companies including Collagen Solutions plc, Stewart is currently CEO of Novel Technologies Holdings Limited and Chairman of Mikota Ltd. Stewart has international executive experience in commercialisation, product development, GMP manufacturing of medical devices, advanced biologics and API’s in both SMEs… Read more »
Innovation Loan for manufacturing scale-up
One of 17 businesses backed in the second round of innovation loans for innovative manufacturing processes and materials. The companies will use the funding to carry out R&D projects as part of plans to scale up production and commercialise new technologies. The Electrospinning Company has just moved into purpose-built clean-room facilities on the growing Harwell Science and Innovation… Read more »
We’ve moved!
Brand new, purpose-built facilities on the Harwell Science and Innovation Campus, a rapidly expanding innovation hub near Oxford in the UK. We are moving into our new unit (#5) in the Zephyr Building on 29th October. The 500 square metre unit is fitted out with four Class VII cleanroom modules, facilitating the segregation of R&D… Read more »
Multiple sclerosis repair roadmap
Research published in the journal Nature provides new understanding about how drugs can repair damaged brain cells that cause disability in patients with multiple sclerosis. Led by researchers at Case Western Reserve University School of Medicine, the study suggests new drug targets and potent early-stage drug candidates could lead to regenerative medicines for multiple sclerosis… Read more »
